Sarah E. Rowan

818 total citations
42 papers, 449 citations indexed

About

Sarah E. Rowan is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Sarah E. Rowan has authored 42 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 23 papers in Infectious Diseases and 11 papers in Hepatology. Recurrent topics in Sarah E. Rowan's work include HIV, Drug Use, Sexual Risk (18 papers), HIV/AIDS Research and Interventions (17 papers) and Hepatitis C virus research (11 papers). Sarah E. Rowan is often cited by papers focused on HIV, Drug Use, Sexual Risk (18 papers), HIV/AIDS Research and Interventions (17 papers) and Hepatitis C virus research (11 papers). Sarah E. Rowan collaborates with scholars based in United States and Italy. Sarah E. Rowan's co-authors include Kevin Kamis, John A. Schneider, Edward M. Gardner, Grace E. Marx, Karen A. Wendel, Steven C. Johnson, Rupa Patel, Dawn K. Smith, Kenneth A. Scott and Peter Vincent and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Sarah E. Rowan

36 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. Rowan United States 12 245 202 82 63 52 42 449
Davide Mangioni Italy 13 273 1.1× 100 0.5× 46 0.6× 31 0.5× 12 0.2× 32 614
Anna Schultze United Kingdom 13 233 1.0× 122 0.6× 50 0.6× 14 0.2× 23 0.4× 42 670
Giorgio Bozzi Italy 15 340 1.4× 141 0.7× 27 0.3× 25 0.4× 9 0.2× 40 613
Charlotte Skinner United Kingdom 11 213 0.9× 124 0.6× 53 0.6× 30 0.5× 3 0.1× 18 447
Maria Axelsson Sweden 8 214 0.9× 183 0.9× 40 0.5× 17 0.3× 10 0.2× 14 336
Florence Huber French Guiana 12 279 1.1× 255 1.3× 37 0.5× 52 0.8× 5 0.1× 35 435
Erin E. Conners United States 12 116 0.5× 311 1.5× 32 0.4× 49 0.8× 27 0.5× 29 523
Miguel Ángel Sánchez-Alemán Mexico 14 86 0.4× 257 1.3× 66 0.8× 52 0.8× 1 0.0× 59 491
Michael R. Nelson United States 14 227 0.9× 42 0.2× 13 0.2× 19 0.3× 9 0.2× 31 614
Tuti Parwati Merati Indonesia 14 335 1.4× 198 1.0× 61 0.7× 42 0.7× 40 493

Countries citing papers authored by Sarah E. Rowan

Since Specialization
Citations

This map shows the geographic impact of Sarah E. Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Rowan more than expected).

Fields of papers citing papers by Sarah E. Rowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Rowan. The network helps show where Sarah E. Rowan may publish in the future.

Co-authorship network of co-authors of Sarah E. Rowan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Rowan. A scholar is included among the top collaborators of Sarah E. Rowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Rowan. Sarah E. Rowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyers, Kathrine, Jason Zucker, Yumeng Wu, et al.. (2025). A case study of the co-creation of the PrEP-SIC: a roadmap to support introduction of pre-exposure prophylaxis into new settings. BMC Health Services Research. 25(1). 631–631. 2 indexed citations
2.
Jones, Austin, Jason S. Haukoos, Emily Hopkins, et al.. (2025). Effect of Routine Opt-Out HIV Screening on Emergency Department Operational Metrics: Results From the Pragmatic Randomized HIV TESTED Trial. Annals of Emergency Medicine. 86(3). 240–251.
3.
Haukoos, Jason S., Michael S. Lyons, Yu‐Hsiang Hsieh, et al.. (2024). 229 Effect of HIV Screening on Emergency Department Patient Throughput. Annals of Emergency Medicine. 84(4). S105–S106. 1 indexed citations
4.
Loy, Dorothy E., et al.. (2024). Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syringe Access Program. Open Forum Infectious Diseases. 11(3). ofae088–ofae088. 4 indexed citations
5.
Holliman, Brooke Dorsey, et al.. (2024). Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduction Journal. 21(1). 140–140. 3 indexed citations
6.
Rowan, Sarah E., et al.. (2023). Mycoplasma genitalium. Medical Clinics of North America. 108(2). 297–310. 1 indexed citations
7.
Rigolon, Alessandro, Jeremy Németh, Priyanka deSouza, et al.. (2023). The neighborhood built environment and COVID-19 hospitalizations. PLoS ONE. 18(6). e0286119–e0286119. 5 indexed citations
8.
Rowan, Sarah E., et al.. (2022). Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. The Journal of Infectious Diseases. 226(Supplement_3). S315–S321. 15 indexed citations
9.
Kamis, Kevin, et al.. (2022). A retrospective, descriptive study of hepatitis C testing, prevalence, and care continuum among adults on probation. Health & Justice. 10(1). 26–26. 4 indexed citations
10.
Kamis, Kevin, Mona Abdo, Edward M. Gardner, et al.. (2021). Risk factors for hospitalization in people with HIV and COVID-19. 29(1). 206–207.
11.
Haukoos, Jason S., Douglas A.E. White, Sarah E. Rowan, et al.. (2021). HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care and STDs. 35(6). 211–219. 17 indexed citations
12.
Haukoos, Jason S., Douglas A.E. White, Sarah E. Rowan, et al.. (2021). Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. The American Journal of Emergency Medicine. 51. 6–12. 5 indexed citations
13.
Rowan, Sarah E., Rupa Patel, John A. Schneider, & Dawn K. Smith. (2020). Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. The Lancet HIV. 8(2). e114–e120. 33 indexed citations
14.
Brooks, Kristina M., José Castillo‐Mancilla, Mary Morrow, et al.. (2020). Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study. Open Forum Infectious Diseases. 8(1). ofaa564–ofaa564. 13 indexed citations
15.
Rowan, Sarah E., et al.. (2019). The Yield of Birth Cohort Screening for Hepatitis C in Community Health Centers. Journal of General Internal Medicine. 34(10). 2003–2004. 1 indexed citations
17.
Kamis, Kevin, Kenneth A. Scott, Edward M. Gardner, et al.. (2018). 859. Same-Day HIV Pre-exposure Prophylaxis (PrEP) Initiation During Drop-in STD Clinic Appointments Is a Safe, Feasible, and Effective Method to Engage Patients at Risk for HIV in PrEP Care. Open Forum Infectious Diseases. 5(suppl_1). S20–S20. 2 indexed citations
18.
Hawkins, Kellie L., Brian T. Montague, Sarah E. Rowan, et al.. (2018). Boosted Darunavir and Dolutegravir Dual Therapy among a Cohort of Highly Treatment-Experienced Individuals. Antiviral Therapy. 24(7). 513–519. 8 indexed citations
19.
Rowan, Sarah E., William J. Burman, Steven C. Johnson, et al.. (2014). Engagement-in-Care During the First 5 Years After HIV Diagnosis: Data from a Cohort of Newly HIV-Diagnosed Individuals in a Large US City. AIDS Patient Care and STDs. 28(9). 475–482. 12 indexed citations
20.
Spinelli, Amy M., José C. González‐Cobos, Xuexin Zhang, et al.. (2012). Airway smooth muscle STIM1 and Orai1 are upregulated in asthmatic mice and mediate PDGF-activated SOCE, CRAC currents, proliferation, and migration. Pflügers Archiv - European Journal of Physiology. 464(5). 481–492. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026